Limes Schlosskliniken AG (FRA:LIK) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


FRA:LIK Limes Schlosskliniken AG FRA:LIK
32 GF Score
Price €530.00
GF Value €496.71
! 3 Warning Signs
View Full Analysis

What is Limes Schlosskliniken AG Research & Development?

Limes Schlosskliniken AG FRA:LIK +1.92% 32 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:LIK with a GF Score™ of 32/100 and a GF Value™ of €496.71. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Limes Schlosskliniken AG's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Limes Schlosskliniken AG  (FRA:LIK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Limes Schlosskliniken AG Research & Development Related Terms

Limes Schlosskliniken AG Research & Development Historical Data

* Premium members only.

The historical data trend for Limes Schlosskliniken AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Limes Schlosskliniken AG Research & Development Chart

Limes Schlosskliniken AG Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Limes Schlosskliniken AG Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:LIK
32GF Score
Limes Schlosskliniken AG FRA:LIK
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Limes Schlosskliniken AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Limes Schlosskliniken AG (FRA:LIK) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Limes Schlosskliniken AG and its competitors.
Is Limes Schlosskliniken AG's Research & Development too high?
Limes Schlosskliniken AG's current Research & Development is €0.00 Mil. Overall, Limes Schlosskliniken AG has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Limes Schlosskliniken AG's Research & Development compare to HCA and THC?
Limes Schlosskliniken AG's Research & Development of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Limes Schlosskliniken AG and its competitors. Limes Schlosskliniken AG's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Limes Schlosskliniken AG stock overvalued right now?
Limes Schlosskliniken AG (FRA:LIK) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €496.71, compared to a current price of €530.00 — trading 6.7% above its estimated fair value. The current Research & Development is €0.00 Mil. Limes Schlosskliniken AG's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Limes Schlosskliniken AG (FRA:LIK), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Limes Schlosskliniken AG (FRA:LIK) Overvalued in 2026?

Based on GuruFocus' analysis, Limes Schlosskliniken AG stock appears to be overvalued. The current stock price of €530.00 is trading 6.7% above its estimated GF Value™ of €496.71.

Key valuation signals for FRA:LIK:

  • Research & Development: €0.00 Mil
  • GF Value™: €496.71 vs. price of €530.00 (6.7% above fair value)
  • GF Score™: 32/100 with 3 warning signs

No single metric tells the full story. See the FRA:LIK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Limes Schlosskliniken AG Business Description

Other Exchanges LIK:Germany
Address Kaiser-Wilhelm-Ring 26, Cologne, NW, DEU, 50672
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
32GF Score

Get the complete analysis for FRA:LIK

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€530.00
Price
€496.71
GF Value